Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured i...

FDA Drug Recall #D-0432-2023 — Class II — February 23, 2023

Recall Summary

Recall Number D-0432-2023
Classification Class II — Moderate risk
Date Initiated February 23, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm The Harvard Drug Group
Location La Vergne, TN
Product Type Drugs
Quantity 17,586 cartons

Product Description

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4

Reason for Recall

Packaging defect: observed packaging defect, blister packaging inadequately sealed.

Distribution Pattern

Distributed Nationwide in the USA

Lot / Code Information

Lot: M04145 Exp. 01/2024

Other Recalls from The Harvard Drug Group

Recall # Classification Product Date
D-0878-2023 Class II Tramadol Hydrochloride Tablets, USP 50 mg, Unit... Jun 16, 2023
D-0570-2023 Class III Gabapentin Tablets, USP 600 mg, packaged in Car... Apr 24, 2023
D-0649-2022 Class II PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 10... Feb 28, 2022
D-0653-2022 Class II hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablet... Feb 24, 2022
D-0807-2021 Class II Carbamazepine 200mg Tablets, USP, 200 mg, 100 C... Aug 6, 2021

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.